Category: FDA & Regulatory Policy

December 21, 2019

Alliance for Aging Research Statement on the FY2020 Budget

WASHINGTON, December 21, 2019 – The Alliance for Aging Research’s (Alliance) President and CEO Susan Peschin, MHS, has released the…
December 13, 2019

Alliance for Aging Research Congratulates Dr. Stephen Hahn on Appointment to FDA Commissioner

      Yesterday the Senate confirmed Dr. Stephen Hahn as the Commissioner of the U.S. Food and Drug…
November 19, 2019

Alliance for Aging Research Supports the Nomination of Dr. Stephen Hahn for FDA Commissioner

On November 18, Alliance for Aging Research President and CEO Sue Peschin, MHS, sent a letter to the Senate on…
March 13, 2019

Alliance for Aging Research Statement on FY 2020 White House Proposed Budget

Alliance for Aging Research President and CEO Susan Peschin, MHS, issued the following statement in response to the White House’s…
June 15, 2018

ACT-AD Coalition Letter on FDA Early Alzheimer’s Disease Guidance

The majority of clinical trials conducted in Alzheimer’s disease have been for patients who received a definitive diagnosis after becoming…
July 12, 2017

Five Questions (and Answers) about the FDA Reauthorization Act of 2017

Right now, the U.S. Congress is considering the FDA Reauthorization Act of 2017 , legislation that will reauthorize the pharmaceutical, medical device, generic drug, and biosimilar user fee agreements. The five-year deal is one of the most important health care bills Congress will vote on this year.
May 23, 2017

Alliance Statement on FY 2018 White House Proposed Budget on NIH, FDA, CDC

Alliance President and CEO Susan Peschin, MHS, has issued the following statement in response to the White House’s proposed Fiscal Year 2018 budget.
April 27, 2017

Alliance Thanks Senate HELP Committee for Advancing FDA Commissioner Nomination of Dr. Scott Gottlieb

Alliance for Aging Research President and CEO Susan Peschin, MHS, has issued the following statement thanking Chairman Lamar Alexander and the U.S. Senate HELP Committee for advancing the nomination of Dr. Scott Gottlieb as U.S. Food and Drug Administration (FDA) commissioner to the full Senate for a vote.
April 21, 2017

Tomorrow Is the March for Science

This Saturday, April 22, thousands of people will gather in the shadow of the Washington Monument to march for not just a cause, but in support of one of humanity’s most important endeavors: science.
April 4, 2017

Alliance’s Bens Offers Testimony on User Fee Programs before Senate HELP Committee

Today, the Alliance for Aging Research's (Alliance) Vice President of Public Policy Cynthia Bens testifies before the U.S. Senate HELP Committee on reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA).